To top
Unité
ANA-MARIA LENNON DUMENIL / OLIVIER LANTZ
Immunité et Cancer (U932)

Créée en 2005, l’Unité U932 INSERM est composée de 10 équipes, réparties sur deux bâtiments (Hôpital Curie et Bâtiment Constant-Burg, rue Lhomond), regroupant environ 160 personnes.

Les équipes de l’Unité tentent de mieux comprendre les réponses immunitaires, et d’apprendre au système immunitaire à mieux lutter contre les agents pathogènes et/ou les tumeurs. Les projets de recherche vont de l’immunologie fondamentale à l’immunothérapie translationnelle et à l’immunothérapie clinique chez des patients atteints de cancer.

 

Chiffres-clés
334
Publications depuis 2017
11
ERC depuis 2008
3
start-ups
Publications clés
Toutes les publications
Actualités
Toutes les actualités
Événements scientifiques
16 Sep
2024
Séminaire Immunology series
11h-23h
Centre de recherche - Paris - Amphithéâtre Constant-Burg - 12 rue Lhomond, Paris 5e
When Nuance Matters: The lesser known side of PD1 signaling
The inhibitory immunoreceptor PD1 is a major cancer immunotherapy target. Anti-PD1 blockade antibodies have become the standard of care for cancer patients, but the low response rate and associated immune related side effects necessitate a better understanding of PD1 mechanism. Best known to be expressed by T cells, PD1 transduces inhibitory signals to attenuate T cell response upon binding to its
10 Sep
2024
Séminaire
14h-23h
Centre de recherche - Paris - Amphithéâtre Marie Curie
“B cell memory in barrier tissues” - " From the bench to the bedside: cancer immunotherapy with soluble T cell receptors"
B cell memory in barrier tissues

During infection, the immune system unleashes protective responses to fight against the pathogen while also establishes a memory compartment that will provide protection in case of a subsequent pathogen encounters. The B cell memory compartment is composed of two layers: long-lived plasma cells (LLPCs) and memory B cells (MBCs). LLPCs mainly migrate to the bone
10 juin
2024
Séminaire
11h-23h
Centre de recherche - Paris - Amphithéâtre Constant-Burg - 12 rue Lhomond, Paris 5e
Functional and molecular characterization of cancer-derived extracellular vesicles
Cancer-derived extracellular vesicles have been demonstrated to play a crucial role in cancer biology. Our team is particularly interested in cancer EV heterogeneity and we have been studying a particular population of extracellular vesicles, known as large oncosomes. These EVs are released by aggressive cancer cells that exhibit cell plasticity and have acquired metastatic abilities.  I will
21 mai
2024
Séminaire
11h-23h
Centre de recherche - Paris - Amphithéâtre Constant-Burg - 12 rue Lhomond, Paris 5e
Nucleosomes and DNA methylation – implications for immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome and cancers
DNA methylation is a broadly observed epigenetic modification. As genomic DNA methylation profiles dynamically change during development and aging, alterations in DNA methylation patterns are linked to diseases such as cancers and immunodeficiency. ICF syndrome is characterized by hypomethylation at heterochromatin. Of four proteins whose mutation cause ICF syndromes (DNMT3B, ZBTB24, CDCA7 and HEL
13 mai
2024
Séminaire
11h-23h
Hôpital site de Paris - Amphithéâtre Hélène Martel-Massignac (BDD)
“Deconstruct-Reconstruct” – Decode cancer-immune crosstalk & probe with organoids.
The Roose team at UCSF studies mechanisms of cell-cell interactions in immunology and cancer1-7, with emphasis on personalized medicine4,8 and single cell approaches9-11. Over the past 7 years, we shifted a large portion of our research efforts to understanding human biology and disease. We are deeply interested in the cellular networks that underpin autoimmune diseases and cancer, which I will ta
Tous les événements scientifiques
Offres d'emploi
Aucune offre d'emploi disponible.
Toutes les offres